Industry Roundup: Prestige Brands, UK Seizure, Optifast Trial
This article was originally published in The Tan Sheet
Executive Summary
Little Remedies markets to health care professionals; supplement label database reaches 50,000; MateFit extends into supplements; and more news in brief.
You may also be interested in...
NIH Supplement Label Database Could Reveal Violative Products
The Office of Dietary Supplements launches its Dietary Supplement Label Database, with about 17,000 product labels. Though the database aims to assist researchers, health care professionals and consumers, regulators looking to flag illegal products might find it useful as well.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.